143 related articles for article (PubMed ID: 24913114)
1. The occurrence of Al amyloidosis (light-chain amyloidosis) in patients with multiple myeloma in Lower Silesia Region, Poland.
Usnarska-Zubkiewicz L; Hołojda J; Jeleń M; Zubkiewicz-Zarębska A; Dębski J; Kuliczkowski K
Adv Clin Exp Med; 2014; 23(2):235-44. PubMed ID: 24913114
[TBL] [Abstract][Full Text] [Related]
2. Asymptomatic immunoglobulin light chain amyloidosis (AL) at the time of diagnostic bone marrow biopsy in newly diagnosed patients with multiple myeloma and smoldering myeloma. A series of 144 cases and a review of the literature.
Siragusa S; Morice W; Gertz MA; Kyle RA; Greipp PR; Lust JA; Witzig TE; Lacy MQ; Zeldenrust SR; Rajkumar SV; Russell SJ; Hayman SR; Buadi F; Kumar SK; Dingli D; Dispenzieri A
Ann Hematol; 2011 Jan; 90(1):101-6. PubMed ID: 20645101
[TBL] [Abstract][Full Text] [Related]
3. Coexistent multiple myeloma or increased bone marrow plasma cells define equally high-risk populations in patients with immunoglobulin light chain amyloidosis.
Kourelis TV; Kumar SK; Gertz MA; Lacy MQ; Buadi FK; Hayman SR; Zeldenrust S; Leung N; Kyle RA; Russell S; Dingli D; Lust JA; Lin Y; Kapoor P; Rajkumar SV; McCurdy A; Dispenzieri A
J Clin Oncol; 2013 Dec; 31(34):4319-24. PubMed ID: 24145344
[TBL] [Abstract][Full Text] [Related]
4. Extracorporeal membrane oxygenation as bridge-to-decision in acute heart failure due to systemic light-chain amyloidosis.
Mancio Silva J; Fontes-Carvalho R; Valente D; Almeida C; Cruz AJ; Tente D; Coelho H; Oliveira M; Albuquerque A; Ribeiro VG
Am J Case Rep; 2015 Mar; 16():174-81. PubMed ID: 25803181
[TBL] [Abstract][Full Text] [Related]
5. Clinical Analysis of Cardiac Involvement in 53 Patients With Multiple Myeloma Coexistent With Light Chain Amyloidosis.
Yu Y; Huang Z; Hu W; Li X; Shen M; Zhang J; Tang R; Chen S; Chen W
Clin Lymphoma Myeloma Leuk; 2020 Aug; 20(8):519-525.e1. PubMed ID: 32389672
[TBL] [Abstract][Full Text] [Related]
6. Incidence and impact of light chain associated (AL) amyloidosis on the prognosis of patients with multiple myeloma treated with autologous transplantation.
Desikan KR; Dhodapkar MV; Hough A; Waldron T; Jagannath S; Siegel D; Barlogie B; Tricot G
Leuk Lymphoma; 1997 Oct; 27(3-4):315-9. PubMed ID: 9402328
[TBL] [Abstract][Full Text] [Related]
7. Clinical features and treatment response of light chain (AL) amyloidosis diagnosed in patients with previous diagnosis of multiple myeloma.
Madan S; Dispenzieri A; Lacy MQ; Buadi F; Hayman SR; Zeldenrust SR; Rajkumar SV; Gertz MA; Kumar SK
Mayo Clin Proc; 2010 Mar; 85(3):232-8. PubMed ID: 20194151
[TBL] [Abstract][Full Text] [Related]
8. [The concurrence of light-chain deposition disease, AL-amyloidosis, and cast nephropathy in a patient with multiple myeloma].
Rekhtina IG; Zakharova EV; Stolyarevich ES; Sinitsina MN; Denisova EN
Ter Arkh; 2015; 87(6):98-101. PubMed ID: 26281203
[TBL] [Abstract][Full Text] [Related]
9. Analysis of free serum light chains in patients suffering from multiple myeloma complicated by light-chain amyloidosis.
Usnarska-Zubkiewicz L; Hołojda J; Dębski J; Zubkiewicz-Zarębska A; Zagocka E; Kuliczkowski K
Adv Clin Exp Med; 2014; 23(4):531-8. PubMed ID: 25166437
[TBL] [Abstract][Full Text] [Related]
10. Trends in Survival and Renal Recovery in Patients with Multiple Myeloma or Light-Chain Amyloidosis on Chronic Dialysis.
Decourt A; Gondouin B; Delaroziere JC; Brunet P; Sallée M; Burtey S; Dussol B; Ivanov V; Costello R; Couchoud C; Jourde-Chiche N
Clin J Am Soc Nephrol; 2016 Mar; 11(3):431-41. PubMed ID: 26728585
[TBL] [Abstract][Full Text] [Related]
11. Multiple myeloma and amyloidosis of the tongue.
Raubenheimer EJ; Dauth J; Pretorius FJ
J Oral Pathol; 1988 Nov; 17(9-10):554-9. PubMed ID: 3150443
[TBL] [Abstract][Full Text] [Related]
12. The prognostic value of diagnosing concurrent multiple myeloma in immunoglobulin light chain amyloidosis.
Dinner S; Witteles W; Witteles R; Lam A; Arai S; Lafayette R; George TI; Schrier SL; Liedtke M
Br J Haematol; 2013 May; 161(3):367-72. PubMed ID: 23432783
[TBL] [Abstract][Full Text] [Related]
13. [Amyloidosis in the course of multiple myeloma].
Mazur G; Usnarska-Zubkiewicz L; Wróbel T; Biedroń M; Nowicka J; Ganczarski G; Kuliczkowski K
Pol Arch Med Wewn; 2005 Apr; 113(4):341-5. PubMed ID: 16209248
[TBL] [Abstract][Full Text] [Related]
14. The prevalence of subclinical amyloidosis in Polish patients with rheumatoid arthritis.
Wiland P; Wojtala R; Goodacre J; Szechinski J
Clin Rheumatol; 2004 Jun; 23(3):193-8. PubMed ID: 15168143
[TBL] [Abstract][Full Text] [Related]
15. Nephrotoxic potential of Bence Jones proteins.
Solomon A; Weiss DT; Kattine AA
N Engl J Med; 1991 Jun; 324(26):1845-51. PubMed ID: 1904132
[TBL] [Abstract][Full Text] [Related]
16. Immunoglobulin light chain amyloidosis associated with multiple myeloma in a young patient: a case report.
Morais OO; Costa LO; Shinzato DH; Hans-Filho G
West Indian Med J; 2010 Mar; 59(2):219-21. PubMed ID: 21275130
[TBL] [Abstract][Full Text] [Related]
17. Congo red-positive cardiac kappa-AL amyloidosis in plasmacytoma -- case report and review of the literature.
Tzankov A; Pölzl G; Mairinger T
Acta Med Austriaca; 2003; 30(1):29-32. PubMed ID: 12558564
[TBL] [Abstract][Full Text] [Related]
18. [Renal disorders associated with monoclonal gammopathies: diagnostic and therapeutic progress].
Bridoux F; Delbes S; Sirac C; Pourreau F; Puyade M; Desport E; Jaccard A; Fermand JP; Touchard G
Presse Med; 2012 Mar; 41(3 Pt 1):276-89. PubMed ID: 22244725
[TBL] [Abstract][Full Text] [Related]
19. [Prognostic factors in light chain amyloidosis].
Jávorniczky NR; Bodó I; Masszi T; Mikala G
Orv Hetil; 2015 Sep; 156(39):1577-84. PubMed ID: 26550915
[TBL] [Abstract][Full Text] [Related]
20. [Multisystemic amyloidosis. Clinical study of 39 patients in Lebanon].
Saba M; Tohmé A; Abadjian G; Haddad F; Ghayad E
Presse Med; 2005 May; 34(9):640-6. PubMed ID: 15988337
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
